Aurasense Medical Inc
Aurasense Medical Inc is a startup pioneering the first neonatal jaundice diagnostic device engineered for melanin-rich skin. Current transcutaneous bilirubinometers systematically underestimate bilirubin by 2 to 5 mg/dL in dark-skinned infants, a silent error that delays life-saving phototherapy and contributes to a disproportionate burden of kernicterus among Black, South Asian, and Indigenous newborns globally. This diagnostic gap represents millions in avoidable healthcare costs, unnecessary painful blood draws, and an active health equity failure embedded in a device used on every newborn in every NICU in the country. We bridge accurate neonatal diagnostics and equitable care using AI-powered spectroscopy and closed-loop phototherapy automation, delivering the first bilirubin reading every baby can trust, regardless of skin tone.
Contact: aurasense.inc@gmail.com; +1 (437)-451-6156